IL37 and COVID-19: Li (110) discovered a link between elevated plasma IL-37 response levels and clinical regression profiles such as shorter length of hospitalization, faster viral nucleic acid negative conversion, earlier CT imaging improvement, faster resolution of cough symptoms, and better benign prognosis in patients with early-stage COVID-19.